2021 BRN Discussion, page-14596

Esq’s ref to donnybrook’s market manipulation, as posted yesterday, particularly in his example re any company with proven and even after being mandated for use products, does come down to such companies being able to balance the books whilst navigating early commercialisation, arguably.

BRN is thankfully not in such a precarious situation, largely because the company is structured for flexibility and holds tight reins at the same time, in my view. Like BRN, EDE has drawn massive interest to itself, undoubtedly because people see great merit in what is on offer.

Donnybrook’s EDE is navigating head winds and clearly has people determined to hamper progress for undisclosed reasons, but that is not of relevance here, except to say that it is imperative to maintain the exceptionally well researched posts that attracted many of us to BRN. esp.